The US Food and Drug Administration (FDA) has approved the first generic version of lenacapavir, the highly effective twice-yearly injection to prevent HIV, developed by Dr Reddy’s Laboratories based in India. Dr Reddy’s was one of six pharmaceutical manufacturers that was granted a non-exclusive, royalty-free voluntary licensing agreement from Gilead, which developed lenacapavir. The agreement, […] Continue reading ->
Returning to lead the Global Fund, Mark Dybul argues that the future of global health lies with domestic health systems, not agency mergers in Geneva. Evoking the founding ambition of the early 2000s, the incoming executive director explains how the Accra Reset and US bilateral aid can align under unified national plans – and how […] Continue reading ->
Former Global Fund executive director Mark Dybul returns to the helm in Geneva, facing an unprecedented $5.32 billion funding gap, fraught domestic transitions, and mounting demands to overhaul the global health architecture. While experts welcome his track record, balancing transatlantic rivalries with rising country sovereignty will demand delicate diplomacy and an updated playbook. The board […] Continue reading ->
The UNAIDS Programme Coordinating Board (PCB) has rejected the proposal by the United Nations Secretary-General that it is “sunsetted” by the end of this year, opting instead to transform into a smaller “hub”. This emerged after the PCB’s special meeting on Monday, which considered a report by a working group on the body’s future. The […] Continue reading ->
HARARE – In March, 27-year-old Jemitius Gangata succumbed to malaria in Mahombokombe village in Zimbabwe’s Mashonaland West Province, becoming part of the country’s growing malaria statistics. By mid-April, the country had recorded over 65,000 malaria cases and 174 deaths, almost double the numbers from the same period last year, when 36,000 cases and 85 deaths […] Continue reading ->
The shortlist of five finalists to serve as the next Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria was published on Wednesday (30 September), launching the final phase of its leadership search. By narrowing the global applicant field to five candidates, the Global Fund’s Executive Director Nomination Committee (EDNC) has taken […] Continue reading ->
Although the United States’ bilateral health memorandums of understanding (MOUs) with 35 countries are due to come into effect on Thursday (1 October), the start of the US fiscal year, the money will not flow yet – as countries have until Friday to submit their final 2027 budgets. And while US officials have hailed the […] Continue reading ->
Country controversies, secret terms, opaque procurement, and massive unspent Congressional funds have characterised the first year of the America First Global Health Strategy. “Services are weaker than they were a year ago, HIV testing is down, treatment of children living with HIV is down, and community-based prevention is gutted,” said Emily Bass, expert consultant for […] Continue reading ->
Countries supported by the Global Fund put over a million more people on antiretroviral (ARV) treatment, sustained tuberculosis treatment and distributed 34 million more insecticide-treated mosquito nets in 2025 than the previous year. In 2025, some 26.9 million people were on ARVs (compared to 25.6 million), 7.4 million people were treated for TB, and 196 […] Continue reading ->
HIV services, mental health and harm reduction programmes have been severely affected by the huge funding cuts to organisations providing services for lesbian, gay, bisexual, transgender, intersex and queer (LGBTIQ) people over the past 18 months. Perversely, organisations in countries with the most repressive conditions for LGBTIQ people have been worst affected by cuts, according […] Continue reading ->